St. Jude Medical Inc., a key rival to Irvine-based Edwards Lifesciences Corp., on Wednesday said quarterly earnings rose, buoyed by a 72% increase in sales of implantable devices that manage rapid heart rhythms.
*For more on this story,
read the full Reuters article.
